Company Atrinsic, Inc. Other OTC
Equities
US04964C2089
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 16-01-31 |
Andrew Slee
COO | Chief Operating Officer | 74 | 16-01-31 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 94-02-02 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-07-27 |
Khalil Barrage
BRD | Director/Board Member | 59 | 07-06-30 |
Timothy Wright
BRD | Director/Board Member | 66 | 22-11-22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 20-07-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PTIX Stock
- Stock
- Company Atrinsic, Inc.